(Q84469578)
Statements
Sequence of administration and methylation of SOCS3 may govern response to gemtuzumab ozogamicin in combination with conventional chemotherapy in patients with refractory or relapsed acute myelogenous leukemia (AML) (English)
Iris Middeldorf
Oliver Galm
Rainhardt Osieka
Edgar Jost
James G Herman